North America Enteral Feeding Formula Market, By Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities) – Industry Trends and Forecast to 2030.
North America Enteral Feeding Formula Market Analysis and Size
According to the World Health Organization, low and middle-income countries account for nearly 70% of cancer fatalities. The enteral feeding formula industry is expanding as a result of rising chronic diseases and disorders, a rapidly ageing population, a rising rate of premature birth, rising healthcare costs, and increased demand for home care. As a result, enteral nutrition uses nasogastric tubes or percutaneous gastric and enteric tubes to bypass the digestive system. These feeding technologies are capable of meeting the needs of the elderly patient. Nonetheless, the rehabilitation of the swallowing system and providing the elderly patient with optimal functionality is primary goal.
Data Bridge Market Research analyses that the enteral feeding formula market, which is USD 1539.58 million in 2022, is expected to reach USD 2625.58 million by 2030, at a CAGR of 6.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Enteral Feeding Formula Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others) Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
Nutricia (Netherlands), Hormel Foods Corporation (U.S.), Medline Industries, Inc. (U.S.), Mead Johnson & Company, LLC. (U.S.), Nestlé Health Science (Switzerland), Abbott (U.S.), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun SE (Germany), Trovita Health Science (U.S.), Victus Inc. (U.S.), Avanos Medical Inc. (U.S.), Cardinal Health (U.S.), Moog Inc (U.S.), Conmed Corporation (U.S.), Cook Medical (India)
|
|
Market Opportunities
|
|
Market Definition
Enteral tube feeding introduces nutrients into the stomach or intestines via tubes for those who are unable to meet their nutritional needs or absorb nutrients orally. For enteral feed formula, tubes such as nasojejunal tubes, nasogastric tubes, gastrostomy tubes, and jejunostomy tubes are available. The various methods for delivering nutrients are inexpensive, nutritious and a viable alternative to invasive surgery.
North America Enteral Feeding Formula Market Dynamics
Drivers
- The rise in the geriatric population
Chronic diseases are spreading across North America as a result of the continually expanding elderly population. The rising geriatric population (those 85 and older) in the EU-27 has numerous effects. As significantly senior persons require proportionally more social services, the cost of ensuring good health and long-term care is one of the key areas of worry for the relevant authorities. The senior population is the market's main target consumer since neurological conditions like multiple sclerosis, stroke, and dementia hinder swallowing.
-
Rise in the incidence of malnutrition
One of the major factors driving the adoption of enteral feeding formulas is an increase in the incidence of malnutrition, which is linked to higher ICU mortality. Malnutrition has a significant death rate in several regions of the world, despite being a common illness that is frequently ignored and underappreciated globally. For instance, malnutrition is thought to be the cause of roughly 45% of fatalities among children under the age of five, with mortality rates higher in low- and middle-income countries. This is the factor which drives the market growth.
Opportunities
- New product launches in the enteral feeding market
A rise in product launches and product development by manufacturers is one of the major factors influencing the market. For instance, Victus, Inc. launched "Abintra Care," a specialised nutritional supplement, in 2020. It contains various essential minerals such as vitamin C, antioxidants, zinc and selenium. This simple-to-use rotating peristaltic pump makes enteral nutrition delivery easier. This device is both safe and accurate because it has sound and light alarm features to warn the user of a pipeline blockage or low battery voltage.
Restraints/Challenges
- Complications associated with enteral feeding
According to the National Center for Biotechnology Information, gastrostomy and jejunostomy feeding tubes are frequently implanted and used for long-term home enteral nutrition support. Although the placement of these tubes is typically accompanied with modest morbidity, prolonged use can lead to a number of issues and diseases that can lower quality of life and have significant cost repercussions. The region's market for enteral feeding formula is slowly expanding due to all of these causes.
This enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2020, China's first ready-to-drink protein-based total nutrition Foods launched by Nestle Health Science for Special Medical Purposes (FSMPs) for malnourished people.
- In June 2020, Enoras Liquid launched by Otuska Pharmaceuitical Factory Inc., an enteral polymeric enteric nutrition.
North America Enteral Feeding Formula Market Scope
The enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Standard formula
- Disease-specific formula
- Diabetic Formula
- Renal Formula
- Hepatic Formula
- Pulmonary Formula
- Peptide-based Formula
- Other Disease Specific Formula
Stage
- Adult
- Pediatric
Indication
- Alzheimer's
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/G.I. Disorder/Diarrhea
- Others
Type of Tube Feeding
- Gastric Tube Feeding
- Nasogastric Tube Feeding
- Gastrostomy Tube Feeding
- Duodenal or Jejunal Tube Feeding
End-user
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
- Nursing Homes
- Assisted Living Facilities
- Home Care Agencies
- Hospices
Enteral Feeding Formula Market Regional Analysis/Insights
The enteral feeding formula market is analyzed and market size insights and trends are provided by country, product, stage, type of tube feeding, indication and end-user as referenced above.
The countries covered in the enteral feeding formula market report are U.S., Canada and Mexico in North America.
The U.S. is dominating in the market and leading the growth in the North America market due to the region's high use of enteral feeding formula, the high rate of preterm births, the rising number of research and development projects, and the region's high adoption of enteral feeding formula for older persons with diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Enteral Feeding Formula Market Share Analysis
The enteral feeding formula market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to enteral feeding formula market.
Some of the major players operating in the enteral feeding formula market are:
- Nutricia (Netherlands)
- Hormel Foods Corporation (U.S.)
- Medline Industries, Inc. (U.S.)
- Mead Johnson & Company, LLC. (U.S.)
- Nestlé Health Science (Switzerland)
- Abbott (U.S.)
- Meiji Holdings Co., Ltd. (Japan)
- Fresenius Kabi AG (Germany)
- B. Braun SE (Germany)
- Trovita Health Science (U.S.)
- Victus Inc. (U.S.)
- Avanos Medical Inc. (U.S.)
- Cardinal Health (U.S.)
- Moog Inc (U.S.)
- Conmed Corporation (U.S.)
- Cook Medical (India)
SKU-